{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,28]],"date-time":"2026-04-28T22:41:22Z","timestamp":1777416082366,"version":"3.51.4"},"reference-count":18,"publisher":"SAGE Publications","issue":"12","license":[{"start":{"date-parts":[[1983,12,1]],"date-time":"1983-12-01T00:00:00Z","timestamp":439084800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/journals.sagepub.com\/page\/policies\/text-and-data-mining-license"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Drug Intelligence &amp; Clinical Pharmacy"],"published-print":{"date-parts":[[1983,12]]},"abstract":"<jats:p>A patient who had repeated episodes of bradycardia while on cisplatin therapy is described. Cisplatin-induced bradycardia has not been reported previously. Deposition of cisplatin in the sinoatrial-node area might explain this cardiotoxic effect. Drug Intell Clin Pharm 1983; 17: 899\u2013901.<\/jats:p>","DOI":"10.1177\/106002808301701207","type":"journal-article","created":{"date-parts":[[2016,5,11]],"date-time":"2016-05-11T12:13:45Z","timestamp":1462968825000},"page":"899-901","source":"Crossref","is-referenced-by-count":15,"title":["Cisplatin-Induced Bradycardia"],"prefix":"10.1177","volume":"17","author":[{"given":"F.","family":"Schlaeffer","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"F.","family":"Tovi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"Leiberman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"179","published-online":{"date-parts":[[1983,12,1]]},"reference":[{"key":"bibr1-106002808301701207","doi-asserted-by":"publisher","DOI":"10.1038\/205698a0"},{"key":"bibr2-106002808301701207","first-page":"317","volume-title":"Cisplatinum\u2014current status and new developments","author":"Durant JR","year":"1980"},{"key":"bibr3-106002808301701207","doi-asserted-by":"crossref","unstructured":"Jacobs C. The role of cisplatinum in the treatment of recurrent head and neck cancer (ibid., 423\u201340).","DOI":"10.1016\/B978-0-12-565050-2.50034-6"},{"key":"bibr4-106002808301701207","unstructured":"Von Hoff D, Elson D. Cisplatinum in lung cancer (ibid., 445\u201358)."},{"key":"bibr5-106002808301701207","doi-asserted-by":"crossref","unstructured":"Rosen G, Niremberg A, Caparros B, Jurgens H, Tah C, Gutierrez M. Cisplatinum in metastatic osteogenic sarcoma (ibid., 465\u201375).","DOI":"10.1016\/B978-0-12-565050-2.50038-3"},{"key":"bibr6-106002808301701207","doi-asserted-by":"crossref","unstructured":"Green A, Hayes FA, Pratt CB, Evans WE, Howarth CB, Senzer N. Phase II evaluation of cisplatinum in children with neuroblastoma and other malignant solid tumors (ibid., 477\u201384).","DOI":"10.1016\/B978-0-12-565050-2.50039-5"},{"key":"bibr7-106002808301701207","first-page":"1527","volume":"63","author":"Von Hoff D","year":"1979","journal-title":"Cancer Treat Rep"},{"key":"bibr8-106002808301701207","first-page":"1523","volume":"63","author":"Krakoff IH","year":"1979","journal-title":"Cancer Treat Rep"},{"key":"bibr9-106002808301701207","first-page":"465","volume":"57","author":"Talley RW","year":"1973","journal-title":"Cancer Chemother Rep"},{"key":"bibr10-106002808301701207","first-page":"178","volume-title":"Recent results in cancer research","volume":"48","author":"Wiltshaw E","year":"1974"},{"key":"bibr11-106002808301701207","first-page":"23","volume":"9","author":"Von Hoff D","year":"1982","journal-title":"Semin Oncol"},{"key":"bibr12-106002808301701207","first-page":"215","volume":"6","author":"Cortes EP","year":"1975","journal-title":"Cancer Chemother Rep"},{"key":"bibr13-106002808301701207","first-page":"195","volume":"6","author":"Minow RA","year":"1975","journal-title":"Cancer Chemother Rep"},{"key":"bibr14-106002808301701207","doi-asserted-by":"publisher","DOI":"10.1002\/1097-0142(197906)43:6<2223::AID-CNCR2820430610>3.0.CO;2-Y"},{"key":"bibr15-106002808301701207","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.1.6124.1422"},{"key":"bibr16-106002808301701207","doi-asserted-by":"publisher","DOI":"10.1002\/cncr.2820360908"},{"key":"bibr17-106002808301701207","first-page":"249","volume-title":"Cisplatinum\u2014current status and development","author":"Dascal Y","year":"1980"},{"key":"bibr18-106002808301701207","doi-asserted-by":"crossref","unstructured":"Manaka RC, Wolf W. Radiopharmacokinetics of cisplatinum (ibid., 271\u201383).","DOI":"10.1016\/B978-0-12-565050-2.50021-8"}],"container-title":["Drug Intelligence &amp; Clinical Pharmacy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1177\/106002808301701207","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1177\/106002808301701207","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,28]],"date-time":"2026-04-28T11:01:25Z","timestamp":1777374085000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.sagepub.com\/doi\/10.1177\/106002808301701207"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1983,12]]},"references-count":18,"journal-issue":{"issue":"12","published-print":{"date-parts":[[1983,12]]}},"alternative-id":["10.1177\/106002808301701207"],"URL":"https:\/\/doi.org\/10.1177\/106002808301701207","relation":{},"ISSN":["0012-6578"],"issn-type":[{"value":"0012-6578","type":"print"}],"subject":[],"published":{"date-parts":[[1983,12]]}}}